Pregnancy and HIV infection in Europe

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 421, 1997, Pages 10-14

  Newell, M L ^a   Thorne, C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST FEEDING; DISEASE COURSE; DISEASE TRANSMISSION; EUROPE; HETEROSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RURAL POPULATION; SEROPREVALENCE; URBAN POPULATION; VERTICAL TRANSMISSION; FEMALE; HUMAN; IMMUNOLOGY; PREGNANCY OUTCOME; PREVALENCE;

DISEASE PROGRESSION; EUROPE; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE;

EID: 0030825517     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. WHO-EC Collaborating Centre on AIDS. AIDS surveillance in Europe. Quarterly report no. 44. Paris: WHO, 1994
2. McCormick A. Unrecognised HIV related deaths. Br Med J 1991; 302: 1365-7
3. Coll O, Torne A, Martinez JM, Rebull E, Carrion A, Ercilla G. Seroprevalence of HIV antibodies in Barcelona obstetrical population. VII International Conference on AIDS, Florence, 1991. EC 3281
4. The Unlinked Anonymous HIV Surveys Steering Group. Unlinked anonymous HIV prevalence monitoring programme: England and Wales. London: HMSO, 1995
5. Bayer E. Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. N Engl J Med 1994; 331: 1223-5
6. Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis 1994; 19: 664-6
7. Holland FJ, Ades AE, Davison CF, Parker S, Berry T, Hjelm M, et al. Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screening 1994; 1: 176-9
8. Dunn DT, Nicoll A, Holland FJ, Davison CF. How much paediatric HIV infection could be prevented by antenatal HIV testing? J Med Screen 1995; 2: 35-40
9. European Collaborative Study. Characteristics of pregnant HIV-1 infected women in Europe. AIDS Care 1996; 8: 33-42
10. Rezza G, Rota MC, Buning E, Hausser D, O'Hare P, Power R. Assessing HIV prevention among injecting drug users in European Community countries: a review. Soc Prevent Med 1994;39Supp 1:561-78
11. Sunderland A, Minkoff HL, Handle A, Moroso G, Landesman S. The impact of human immunodeficiency virus serostatus on reproductive decisions of women. Obstet Gynecol 1992; 79: 1027-31
12. Selwyn PA, Carter RJ, Schoenbaum EE, Robertson FJ, Klein RS, Rogers MF. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989; 261:3567-71
13. Johnstone FD, Brettle RP, MacCallum LR, Mok J, Peutherer JF, Burns S. Women's knowledge of their HIV antibody state: its effect on their decision whether to continue the pregnancy. Br Med J 1990; 300: 23-4
14. Kline A, Strickler J, Kempf J. Factors associated with pregnancy and pregnancy resolution in HIV seropositive women. Soc Sci Med 1995; 40: 1539-47
15. Rogers MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is opened. N Engl J Med 1994; 331: 1222-3
16. European Collaborative Study. Clinical and immunological characteristics of HIV-1 infected pregnant women. Br J Obstet Gynaecol 1995;102: 869-75
17. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339: 1007-12
18. Scaravelli G, Thorne C, Newell M. The management of pregnancy and delivery in HIV infected women in Europe. Eur J Obstet Gynecol Reprod Biol 1995; 62: 7-13
19. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994:331: 1173-80
20. Johnstone FD. Pregnancy outcome and pregnancy management in HIV-infected women. In: Johnson MA, Johnstone FD, editors. HIV infection in women. London: Longman, 1996
21. Selwyn PA, Schoenbaum EE, Davenny K, Robertson VJ, Feingold AR, Shulman JFE. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989; 261: 1289-94
22. Minkoff HL, Henderson C, Mendez H, Gail MH, Holman S, Willoughby A, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990; 163: 1598-604
23. Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, et al. The incidence of complications after caesarean section in 156 HIV positive women. AIDS 1995; 9: 913-7
24. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464-7
25. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. International Registry of HIV-exposed Twins. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Pediatr 1995; 126: 625-32
26. +levels. J Acq Immune Defic Syndr 1994; 7: 718-26
27. Lepage P, Dabis F, Hitimana D, Msellati P, Van GC, Stevens A, et al. Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS 1991; 5: 295-300
28. Halsey NA, Boulos R, Holt E, et al. Transmission of HIV-1 infections from mothers to infants in Haiti. JAMA 1991; 264: 2088-92
29. Alger LS, Parley JJ, Robinson BA, Mines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993; 82: 787-96
30. Temmerman M, Chomba EN, Ndinya-Achola J, Plummer FA, Coppens M, Piot P. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994; 83: 495-501
31. Ryder RW, Nsa W, Hassig SE, Behets F, Rayfield M, Ekungola BE. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989; 320: 1637-42
32. European Collaborative Study. Perinatal findings in children born to HIV-infected mothers. Br J Obstet Gynaecol 1994; 101: 136-41
33. Blanche S, Rouzioux C, Guihard MM, Veber F, Mayaux M, Jacomet C. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989; 320: 1643-8
34. Scott GB, Fischl MA, Klimas N, Fletcher MA, Dickinson GM, Levine RS, et al. Mothers of infants with the acquired immunodeficiency syndrome evidence for both symptomatic and asymptomatic carriers. JAMA 1985; 253: 363-6
35. Minkoff H, Nanda D, Meneg R, Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: follow-up of mothers, children and subsequent born siblings. Obstet Gynecol 1987; 69(3): 288-91
36. Berrebi A, Kobuch WE, Fuel J. Influence of pregnancy on human immunodeficiency virus disease. Eur J Obstet Gynecol Reprod Biol 1990;37:211-7
37. Maynard EC, Oh W. Human immunodeficiency virus infection and pregnancy outcome in intravenous drug users. Am J Dis Child 1990; 144: 1181-3
38. Mulcahy F, Kelly G, Tynan M. The natural history of HIV infection in women attending a sexually transmitted disease clinic in Dublin. Genitourin Med 1994; 70: 81-3
39. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. The Italian Seroconversion Study. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Br Med J 1994; 309: 1537-42
40. Morlat P, Parneix P, Douard D, et al. Women and HIV injection: a cohort study of 483 HIV-infected women in Bordeaux, France 1985-1991. AIDS 1992; 6: 1187-93
41. Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990; 4: 125-9
42. Biggar RJ, Pahwa S, Minkhoff H, Mendes H, Willoughby A, Landesman S, et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol 1989; 161: 1239-44
43. Miotti PG, Liomba G, Dallabetta GA, Hoover DR, Chiphangwi JD, Saah AJ. T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency type 1-infected and -uninfected Malawian mothers. J Infect Dis 1992; 165: 1116-9
44. Temmerman M, Nagelkerke N, Bwayo J, Chomba EN, Ndinya-Achola J, Piot P. HIV-1 and immunological changes during pregnancy: a comparison between HIV-1 seropositive and HIV-1 seronegative women in Nairobi, Kenya. AIDS 1995; 9: 1057-60
45. Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM, Bird AG. HIV infection in women: immunological markers and the influence of pregnancy. AIDS 1995; 9: 1177-84
46. Giaquinto C, Giacomet V, Pagliaro A, Ruga E, Cozzani S, D'Elia R, el al. Social care of children born to HIV-infected parents. Lancet 1992; 339: 189-90
47. Kind C, Brandle B, Wyler C, Calame A, Rudin C, Schaad UB, et al. Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992; 151:442-8